Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2008-04-22
2008-04-22
Puttlitz, Karl (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S532000, C514S534000, C560S070000, C560S070000, C562S433000, C562S471000
Reexamination Certificate
active
07361686
ABSTRACT:
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyper-lipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; m is 2 or 3; q is 0 or 1; t is 0 or 1; R2is alkyl having from 1 to 3 carbon atoms; R3is hydrogen, halo, alkyl having from 1 to 3 atoms, or alkoxy having from 1 to 3 carbon atoms; A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or cycloalkyl having from 3 to 6 ring carbon atoms wherein the cycloalkyl is unsubstituted or one or two ring carbons are independently mono-substituted by methyl or ethyl; or a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently bound to the remainder of the compound of formula I by a ring carbon; and R1is hydrogen or alkyl having 1 or 2 carbon atoms. Alternatively, when R1is hydrogen, the biologically active agent can be a pharmaceutically acceptable salt of the compound of Formula (I)
REFERENCES:
patent: 4897397 (1990-01-01), Shih et al.
patent: 5604225 (1997-02-01), Reiffen et al.
patent: 5932601 (1999-08-01), Sohda et al.
patent: 6156781 (2000-12-01), Talley et al.
patent: 6858602 (2005-02-01), Sharma et al.
patent: 6916848 (2005-07-01), Sharma
patent: 6924314 (2005-08-01), Sharma et al.
patent: 6946491 (2005-09-01), Sharma et al.
patent: 7012071 (2006-03-01), Sharma et al.
patent: 7041659 (2006-05-01), Sharma
patent: 7045541 (2006-05-01), Sharma
patent: 7101910 (2006-09-01), Sharma et al.
patent: 2005/0090555 (2005-04-01), Sharma et al.
patent: 2005/0256333 (2005-11-01), Sharma et al.
patent: 2006/0014784 (2006-01-01), Hodge et al.
patent: 2006/0035970 (2006-02-01), Hodge et al.
patent: 2006/0247309 (2006-11-01), Hodge et al.
patent: 2007/0105958 (2007-05-01), Sharma et al.
patent: 2007/0173544 (2007-07-01), Hodge et al.
patent: 3419952 (1985-11-01), None
patent: 95/04025 (1995-02-01), None
patent: WO02/053547 (2002-07-01), None
patent: WO02/100341 (2002-12-01), None
patent: 2004/041165 (2004-05-01), None
patent: 2004/073611 (2004-09-01), None
Nogradi et al. Models in Chemistry 1998, 135(1-2), pp. 57-78.
Pending claims from U.S. Appl. No. 10/531,618, filed Apr. 14, 2005.
Abstract for DE 3,419,952, Kristen, et al., “New 3-phenoxy-phenyl propionic acid derivs.-13 useful as herbicides, defoliants and desiccants”.
Nogradi, et al., “The unwanted synthesis of (E,E)-4,21-dimethoxy-2-19-dioxahexacyclo[30,2,2,215,18,13,7,120,24] tetratriacontan-3,5,7(35),13,15,17,20,22,24(38),30,32,34,36,39-tetradecaen-12,29-dione and other attempts at the synthesis of acerogenins” Models in Chemistry, 135(1-2), pp. 57-78, 1998. (abstract).
Pending (as of Dec. 13, 2006) claims from U.S. Appl. No. 10/532,690.
Pending (as of Aug. 20, 2007) claims from U.S. Appl. No 11/481,508.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,501.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,504.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,511.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,515.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,520.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,556.
Pending (as of Jul. 2, 2007) claims from U.S. Appl. No 11/772,560.
Pending (as of Aug. 24, 2007) claims from U.S. Appl. No 11/844,431.
Pending (as of Aug. 24, 2007) claims from U.S. Appl. No 11/844,432.
Pending (as of Aug. 20, 2007) claims from U.S. Appl. No. 11/841,489.
Pending (as of Sep. 20, 2007) claims from U.S. Appl. No. 10/566,302.
Pending (as of Sep. 19, 2007) claims from U.S. Appl. No. 11/909,120.
Younis, et al., “The prevention of type 2 diabetes mellitus: recent advances”, QJ Med., vol. 97, pp. 451-455, 2004.
Goff, et al., “Prevention of Cardiovascular Disease in Persons with type 2 diabetes Mellitus: Current Knowledge and Rational for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial”, AM J Cardiol., 99(12A): s4-S20, 2007. (Abstract).
Knowler, et al., “Perspectives in Diabetes: Preventing Non-Insulin-Dependent Diabetes”, Diabetes, vol. 44, pp. 483-488, 1995.
Hodge Kirvin L.
Kaufman Robert
Lee Albert C.
Sharma Shalini
von Borstel Reid W.
Kreisler Lewis J.
Puttlitz Karl
Valenrod Yevgeny
Wellstat Therapeutics Corporation
LandOfFree
Compounds for the treatment of metabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for the treatment of metabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of metabolic disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2774288